Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Epigenetic programming of hematopoietic stem cells and their progeny.


   Radcliffe Department of Medicine

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Prof Claus Nerlov, Prof D Higgs, Prof S E Jacobsen  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

The blood system produces more than ten mature cellular lineages all of which are derived from a small (1:10,000) pool of multi-potent, self-renewing hematopoietic stem cells (HSCs). Until recently, HSCs were thought to be a uniform cell population, and that the lineage commitment and differentiation of their progeny was determined by the stochastic action of lineage instructive transcription factors. However, it is now clear that distinct HSC populations exist which preferentially produce one subset of hematopoietic progenitors and differentiated cell types, but contribute little, or not at all, to other lineages.

We recently identified a HSC subpopulation with a strong platelet bias (Sanjuan-Pla et al., Nature 2013), and showed that these platelet-biased HSCs can give rise to HSCs with either myeloid or lymphoid lineage bias, but not vice-versa, suggesting that HSC populations are hierarchically organized, as are downstream, lineage-restricted progenitors.

We now wish to determine how these HSC subtypes are specified, and how their lineage bias is maintained. In particular, we want to understand how one type of lineage bias can replace another, and whether the epigenetic programme in biased HSC subtypes differ from those in the downstream lineage committed progenitors and their differentiating progeny.

To gain insight into these processes we will develop highly sensitive global profiling of the chromatin state of all cis-acting elements (e.g. enhancers, promoters and boundary elements) associated with platelet, myeloid and lymphoid lineage programs in pre-programmed HSCs and in the corresponding fully committed progenitors. This will allow the epigenetic profiles associated with bias and commitment to be directly compared. These studies will be combined with global RNA sequencing to identify putative mediators of the observed differences between chromatin states, including lincRNAs, transcription factors and chromatin modifications.

Funding Notes

Funding for this project is available to basic scientists through the RDM Scholars Programme, which offers funding to outstanding candidates from any country. Successful candidates will have all tuition and college fees paid and will receive a stipend of £18,000 per annum.

For October 2017 entry, the application deadline is 6th January 2017 at 12 noon (midday).

Please visit our website for more information on how to apply.

How good is research at University of Oxford in Clinical Medicine?


Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities